5262.T
Nippon Hume Corporation [5262.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
5262.T Stock Summary
Top 10 Correlated ETFs
5262.T
Top 10 Correlated Stocks
5262.T
In the News
5262.T Financial details
Company Rating
Buy
Market Cap
23.09B
Income
1.6B
Revenue
31.36B
Book val./share
-
Cash/share
-
Dividend
21
Dividend %
2.2%
Employees
508
Optionable
No
Shortable
Yes
Earnings
08 Feb 2024
P/E
14.29
Forward P/E
-
PEG
-2.96
P/S
0.75
P/B
0.58
P/C
-
P/FCF
-
Quick Ratio
1.85
Current Ratio
2.43
Debt / Equity
0.03
LT Debt / Equity
-
-
-
EPS (TTM)
45.42
EPS next Y
-
EPS next Q
-
EPS this Y
-22.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.83%
Revenue last 5Y
-3.46%
Revenue Q/Q
-4.24%
EPS Q/Q
-
-
-
-
-
SMA20
6.85%
SMA50
2.95%
SMA100
19.62%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.02%
Gross Margin
17%
Oper. Margin
3%
Profit Margin
5%
Payout
-
Shs Outstand
24.75M
Shs Float
20.52M
-
-
-
-
Target Price
-
52W Range
627.0-933.0
52W High
+2.04%
52W Low
+51.83%
RSI
71.4
Rel Volume
0.48
Avg Volume
66.72K
Volume
32.1K
Perf Week
4.04%
Perf Month
10.31%
Perf Quarter
26.43%
Perf Half Y
28.65%
-
-
-
-
Beta
0.495
-
-
Volatility
17.81%, 27.41%
Prev Close
-0.1%
Price
952
Change
0.74%
5262.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.53K | 1.43K | 1.25K | 1.21K | 1.32K | |
| Net income per share | 82.81 | 85.83 | 87.17 | 87.95 | 68.12 | |
| Operating cash flow per share | 152.94 | 71.77 | 147.29 | 40.06 | 26.96 | |
| Free cash flow per share | 104.72 | 34.71 | 118.39 | 20.66 | -1.54 | |
| Cash per share | 434.07 | 413.37 | 491.29 | 527.04 | 506.58 | |
| Book value per share | 1.28K | 1.34K | 1.46K | 1.51K | 1.57K | |
| Tangible book value per share | 1.29K | 1.35K | 1.47K | 1.51K | 1.58K | |
| Share holders equity per share | 1.28K | 1.34K | 1.46K | 1.51K | 1.57K | |
| Interest debt per share | 50.7 | 39.66 | 38.51 | 40.96 | 45.06 | |
| Market cap | 19.42B | 15.31B | 18.69B | 16.78B | 18.08B | |
| Enterprise value | 9.6B | 5.87B | 7.29B | 4.7B | 6.69B | |
| P/E ratio | 9.46 | 7.27 | 8.78 | 7.86 | 11.01 | |
| Price to sales ratio | 0.51 | 0.44 | 0.61 | 0.57 | 0.57 | |
| POCF ratio | 5.12 | 8.69 | 5.19 | 17.25 | 27.82 | |
| PFCF ratio | 7.48 | 17.98 | 6.46 | 33.44 | -488.44 | |
| P/B Ratio | 0.61 | 0.47 | 0.52 | 0.46 | 0.48 | |
| PTB ratio | 0.61 | 0.47 | 0.52 | 0.46 | 0.48 | |
| EV to sales | 0.25 | 0.17 | 0.24 | 0.16 | 0.21 | |
| Enterprise value over EBITDA | 2.94 | 1.76 | 2.17 | 1.46 | 2.46 | |
| EV to operating cash flow | 2.53 | 3.34 | 2.03 | 4.83 | 10.29 | |
| EV to free cash flow | 3.7 | 6.9 | 2.52 | 9.36 | -180.74 | |
| Earnings yield | 0.11 | 0.14 | 0.11 | 0.13 | 0.09 | |
| Free cash flow yield | 0.13 | 0.06 | 0.15 | 0.03 | 0 | |
| Debt to equity | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Debt to assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Net debt to EBITDA | -3.01 | -2.82 | -3.39 | -3.76 | -4.18 | |
| Current ratio | 1.94 | 2.06 | 2.3 | 2.34 | 2.24 | |
| Interest coverage | 61.66 | 64.12 | 134.17 | 114.09 | 78.08 | |
| Income quality | 1.39 | 0.66 | 1.36 | 0.35 | 0.3 | |
| Dividend Yield | 0.02 | 0.03 | 0.03 | 0.04 | 0.03 | |
| Payout ratio | 0.21 | 0.22 | 0.22 | 0.29 | 0.3 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0 | 0 | 0.01 | 0.01 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.32 | -0.52 | -0.2 | -0.48 | -1.06 | |
| Capex to revenue | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 | |
| Capex to depreciation | -1.82 | -1.36 | -1.11 | -0.69 | -1.13 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.55K | 1.61K | 1.69K | 1.73K | 1.55K | |
| ROIC | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | |
| Return on tangible assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | |
| Graham Net | 167.21 | 192.09 | 234.11 | 287.52 | 207.22 | |
| Working capital | 12.81B | 13.07B | 13.76B | 15.44B | 15.99B | |
| Tangible asset value | 31.97B | 33.04B | 35.83B | 36.76B | 38.01B | |
| Net current asset value | 9.11B | 9.55B | 9.97B | 11.74B | 12.16B | |
| Invested capital | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Average receivables | 13.87B | 12.2B | 10.33B | 9.53B | 10.14B | |
| Average payables | 11.14B | 10.4B | 9.12B | 8.32B | 9.33B | |
| Average inventory | 2.49B | 2.76B | 3.01B | 3.19B | 3.71B | |
| Days sales outstanding | 120.07 | 123.78 | 105.14 | 127.24 | 114.54 | |
| Days payables outstanding | 121.19 | 126.53 | 118.73 | 129.85 | 139.69 | |
| Days of inventory on hand | 29.08 | 36.88 | 44.98 | 50.49 | 56.67 | |
| Receivables turnover | 3.04 | 2.95 | 3.47 | 2.87 | 3.19 | |
| Payables turnover | 3.01 | 2.88 | 3.07 | 2.81 | 2.61 | |
| Inventory turnover | 12.55 | 9.9 | 8.12 | 7.23 | 6.44 | |
| ROE | 0.06 | 0.06 | 0.06 | 0.06 | 0.04 | |
| Capex per share | -48.22 | -37.06 | -28.9 | -19.39 | -28.49 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 297.62 | 338.48 | 368.59 | 304.79 | 0 | |
| Net income per share | 21.81 | 7.11 | 11.78 | 26.48 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 568.84 | 508.71 | 517.98 | 520.81 | 0 | |
| Book value per share | 1.53K | 1.55K | 1.58K | 1.6K | 0 | |
| Tangible book value per share | 1.55K | 1.56K | 1.58K | 1.61K | 0 | |
| Share holders equity per share | 1.53K | 1.55K | 1.58K | 1.6K | 0 | |
| Interest debt per share | 43.08 | 43.94 | 44.66 | 45.05 | 0 | |
| Market cap | 15.18B | 15.53B | 18.04B | 18.58B | 0 | |
| Enterprise value | 2.49B | 4.33B | 6.65B | 6.88B | -11.57B | |
| P/E ratio | 7.21 | 22.68 | 15.92 | 7.3 | 0 | |
| Price to sales ratio | 2.11 | 1.91 | 2.03 | 2.54 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0.41 | 0.42 | 0.48 | 0.48 | 0 | |
| PTB ratio | 0.41 | 0.42 | 0.48 | 0.48 | 0 | |
| EV to sales | 0.35 | 0.53 | 0.75 | 0.94 | -1.65 | |
| Enterprise value over EBITDA | 3.96 | 16.29 | 15.25 | 11.83 | -21.23 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0.03 | 0.01 | 0.02 | 0.03 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Debt to assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Net debt to EBITDA | -20.22 | -42.09 | -26.12 | -20.11 | -21.23 | |
| Current ratio | 2.33 | 2.31 | 2.24 | 2.35 | 2.43 | |
| Interest coverage | 60 | 55.12 | 126.81 | 12.59 | 31.22 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 867.76 | 497.82 | 646.02 | 977.12 | 0 | |
| ROIC | 0.01 | 0 | 0.01 | 0 | 0 | |
| Return on tangible assets | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Graham Net | 302.28 | 283.58 | 217.99 | 212.9 | 0 | |
| Working capital | 15.52B | 15.86B | 15.99B | 15.87B | 16.23B | |
| Tangible asset value | 37.16B | 37.4B | 38.01B | 38.62B | 39.3B | |
| Net current asset value | 11.91B | 12.08B | 12.16B | 11.73B | 12.03B | |
| Invested capital | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Average receivables | 9.36B | 10.03B | 10.54B | 9.29B | 8.46B | |
| Average payables | 9.01B | 9.55B | 10.02B | 9.59B | 8.81B | |
| Average inventory | 3.86B | 4.25B | 4.21B | 4.13B | 4.32B | |
| Days sales outstanding | 112.44 | 122.4 | 101.52 | 105.44 | 107.09 | |
| Days payables outstanding | 138.26 | 130.04 | 126.38 | 131.37 | 134.57 | |
| Days of inventory on hand | 63.14 | 56.46 | 51.27 | 60.29 | 70.56 | |
| Receivables turnover | 0.8 | 0.74 | 0.89 | 0.85 | 0.84 | |
| Payables turnover | 0.65 | 0.69 | 0.71 | 0.69 | 0.67 | |
| Inventory turnover | 1.43 | 1.59 | 1.76 | 1.49 | 1.28 | |
| ROE | 0.01 | 0 | 0.01 | 0.02 | 0.01 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
5262.T Frequently Asked Questions
What is Nippon Hume Corporation stock symbol ?
Nippon Hume Corporation is a JP stock and trading under the symbol 5262.T
What is Nippon Hume Corporation stock quote today ?
Nippon Hume Corporation stock price is $952 today.
Is Nippon Hume Corporation stock public?
Yes, Nippon Hume Corporation is a publicly traded company.
Company Profile
- Volume Average 66.72K
- Market Capitalization 23.09B
- Employee 508
- CEO Mr. Tomoyuki Masubuchi
- Headquarters Tokyo,JP
- IPO Date 2001-01-01
-
Website
https://www.nipponhume.co.jp 
Nippon Hume Corporation designs, manufactures, and sells concrete secondary products in Japan and internationally. The company offers pipeline products, such as hume tubes and synthetic steel pipes, box and arch culverts, assembly manholes, precast joint grooves, wellman products, jip pipes, propulsion pipes, optical fiber compatible products, and antibacterial concrete products; concrete piles; RC segments and FN fittings; and PC and composite wells, and press casts and PRC hollow piers. It also provides multi-arch divided systems, precast guard fences, EMC wall rails, and wall railings; and valve boxes, precast retarding basins, and eco concrete products, as well as optical fiber cables. Further, the company is involved in the construction contracting, and civil engineering and telecommunications works; sale of concrete products and big agents; sports business; manufacture, sale, design, and equipment construction of deplant deodorization system; maintenance of buildings; manufacture and sale of formwork for concrete products; real estate business; laying business; and pipeline diagnosis business. The company was founded in 1925 and is headquartered in Tokyo, Japan.
